The ROE as of September 2024 (TTM) for Ironwood Pharmaceuticals, Inc. (IRWD) is -2.78%

According to Ironwood Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -2.78%. This represents a change of 288.65% compared to the average of -0.72% of the last 4 quarters.

Ironwood Pharmaceuticals, Inc. (IRWD) Historical ROE (quarterly & annually)

How has IRWD ROE performed in the past?

The mean historical ROE of Ironwood Pharmaceuticals, Inc. over the last ten years is -94.08%. The current -2.78% ROE has changed -97.04% with respect to the historical average. Over the past ten years (40 quarters), IRWD's ROE was at its highest in in the September 2020 quarter at 583.05%. The ROE was at its lowest in in the June 2017 quarter at -908.09%.

Ironwood Pharmaceuticals, Inc. (IRWD) ROE by Quarter and Year

Discovering the peaks and valleys of Ironwood Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Ironwood Pharmaceuticals, Inc. (IRWD) Average ROE

How has IRWD ROE performed in the past?

The current ROE of Ironwood Pharmaceuticals, Inc. (IRWD) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Ironwood Pharmaceuticals, Inc. (IRWD) ROE vs. Peers

How is IRWD’s ROE compared to its peers?

Ironwood Pharmaceuticals, Inc.’s ROE is less than Neurocrine Biosciences, Inc. (14.86%), less than Amphastar Pharmaceuticals, Inc. (25.42%), less than Collegium Pharmaceutical, Inc. (49.14%), less than ANI Pharmaceuticals, Inc. (6.02%), less than Alkermes plc (22.66%), greater than Intra-Cellular Therapies, Inc. (-11.48%), greater than Deciphera Pharmaceuticals, Inc. (-52.42%), less than Pacira BioSciences, Inc. (7.32%), greater than Avadel Pharmaceuticals plc (-122.60%), less than Eagle Pharmaceuticals, Inc. (4.41%), greater than Assertio Holdings, Inc. (-231.03%), less than Esperion Therapeutics, Inc. (26.20%),

Build a custom stock screener for Ironwood Pharmaceuticals, Inc. (IRWD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ironwood Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ironwood Pharmaceuticals, Inc. (IRWD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ironwood Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.